Upgrade to SI Premium - Free Trial

Sarepta Therapeutics (SRPT) PT Raised to $270 at JMP Securities

December 13, 2019 4:38 AM
JMP Securities analyst Liisa Bayko ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles